C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/16 (2006.01) A61K 38/26 (2006.01) A61P 1/00 (2006.01) C07K 14/065 (2006.01) C07K 14/605 (2006.01)
Patent
CA 2502324
The present invention relates to novel human glucagon-like peptide-2 (GLP-2) peptides and human glucagon-like peptide-2 derivatives which have a protracted profile of action due to increased resistance to degradation as well as polynucleotide constructs encoding such peptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
L'invention concerne de nouveaux peptides (GLP-2) peptide 2 du type glucagon, des dérivés de peptide 2 humain, du type glucagon, présentant un profil d'action prolongé, ainsi que des constructions de polynucléotide codant pour de tels peptides, des vecteurs et cellules hôtes comprenant et exprimant le polynucléotide, des compositions pharmaceutiques, des utilisations et des procédés de traitement.
Bang Susanne
Engelund Dorthe Kot
Johansen Nils Langeland
Kaarsholm Niels Christian
Madsen Kjeld
Dimock Stratton Llp
Novo Nordisk A/s
LandOfFree
Glucagon - like peptide - 2 variants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucagon - like peptide - 2 variants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon - like peptide - 2 variants will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1767915